Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Editorial: the geriatrician, the primary care physician, aducanumab and the FDA decision: from frustration to new hope
It bypasses the skin barrier problem entirely
Coordination of Discovery: Legal observers anticipate that coordination of these cases will facilitate more efficient discovery processes and potentially expedite resolution timelines for affected patients
Efficacy and safety of maintenance ustekinumab for ulcerative colitis through 3 Years: UNIFI Long-term extension
US$ 26.57
US$ 25.05
US$ 26.65
US$ 22.59
US$ 28.76
